| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,830 |
3,555 |
$202K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,874 |
2,502 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,485 |
1,389 |
$61K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,335 |
960 |
$31K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,721 |
1,458 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,036 |
675 |
$21K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
499 |
253 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
122 |
113 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
185 |
178 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
598 |
461 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
179 |
145 |
$6K |
| 81514 |
|
93 |
91 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
582 |
445 |
$6K |
| 99441 |
|
723 |
599 |
$6K |
| 99233 |
Prolong inpt eval add15 m |
308 |
82 |
$5K |
| 99442 |
|
150 |
122 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
65 |
44 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
474 |
269 |
$2K |
| 87276 |
|
454 |
262 |
$1K |
| 87529 |
|
158 |
79 |
$1K |
| 87563 |
|
185 |
175 |
$1K |
| 87275 |
|
454 |
262 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15 |
13 |
$1K |
| 87653 |
|
199 |
189 |
$899.97 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
91 |
91 |
$655.99 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
91 |
91 |
$655.99 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
58 |
43 |
$611.72 |
| 87640 |
|
79 |
79 |
$598.50 |
| 80061 |
Lipid panel |
41 |
36 |
$310.50 |
| 87481 |
|
78 |
36 |
$176.88 |
| 80053 |
Comprehensive metabolic panel |
35 |
26 |
$137.93 |
| 80305 |
|
16 |
15 |
$137.54 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$125.27 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
71 |
51 |
$123.03 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
12 |
$94.66 |
| 87500 |
|
39 |
36 |
$58.96 |
| 87641 |
|
38 |
35 |
$58.96 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
332 |
316 |
$16.75 |
| 1036F |
|
231 |
212 |
$0.00 |
| 3008F |
|
501 |
474 |
$0.00 |
| 3074F |
|
209 |
197 |
$0.00 |
| 3079F |
|
12 |
12 |
$0.00 |
| 1126F |
|
82 |
77 |
$0.00 |
| 1111F |
|
80 |
77 |
$0.00 |
| 3078F |
|
178 |
170 |
$0.00 |
| 1159F |
|
92 |
81 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
25 |
25 |
$0.00 |
| 1160F |
|
118 |
106 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
51 |
47 |
$0.00 |
| G0312 |
Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes) |
14 |
14 |
$0.00 |
| 99173 |
|
27 |
27 |
$0.00 |